prikaz prve stranice dokumenta Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling
No public access
master's thesis
Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling

Vukušić, Kristina
University of Rijeka
Faculty of Biotechnology and Drug Development

Cite this document

Vukušić, K. (2016). Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling (Master's thesis). Rijeka: University of Rijeka. Retrieved from https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Master's thesis, University of Rijeka, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Master's thesis, University of Rijeka, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, K. (2016). 'Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling', Master's thesis, University of Rijeka, accessed 15 September 2024, https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić K. Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling [Master's thesis]. Rijeka: University of Rijeka; 2016 [cited 2024 September 15] Available at: https://urn.nsk.hr/urn:nbn:hr:193:483208

K. Vukušić, "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling", Master's thesis, University of Rijeka, Rijeka, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:193:483208

Please login to the repository to save this object to your list.